Decision Diagnostics Corp (DECN)

[DrZem]

Does Note 6 from the 1Q 2016 Financial Report help clarify?

"NOTE 6 – Acquisition of Certain Properties
In March 2014 the Company agreed to acquire certain properties from Shasta Technologies LLC. The agreement
covering this acquisition is now the subject of two litigations, one litigation related to the remaining proceeds of an IP
defense insurance policy, the other litigation concerning damages the company is trying to collect from Shasta
Technologies LLC owing to Shasta’s subsequent undisclosed issues with the U.S. FDA. The original purchase price
for this property was expected to be $2,000,000 (cash). The company is anticipating offsets much higher than the assets
purchase price and will pursue collection of these additional offsets at an appropriate time. The Company has not yet
recorded this acquisition on its books because the acquisition terms have not yet been fully determined and the final
acquisition price to be determined by the court. The company did register this FDA cleared product with the U.S. FDA
in 2014 and 2015 and reregistered the product again in 2016 knowing that a new registration process would be required
to adhere to the U.S. FDA UDI mandate to go into effect in September 2016.
Establishment
Name Registration
Number
Current
Registration Yr
Pharma Tech Solutions, Inc CA/USA 3008282042 2016
? Glucose Oxidase, Glucose - Alltara™; GenStrip50™;
GenUltimate!™
Manufacturer; Specification Developer;
Complaint File Establishme